Information Letter on Zomacton® (somatropin): change in the trade names of the injection equipment for administering the drugs
2020.04.16
Active substance: somatropin
The company Ferring Arzneimittel GmbH informs in coordination with the Federal Institute for Drugs and Medical Devices (BfArM) that the needle-free injection device ZomaJet 2 Vision for the administration of Zomacton® 4 mg has been renamed ZomaJet 4 and the needle-free injection device ZomaJet Vision X for the administration of Zomacton® 10 mg/ml has been renamed ZomaJet 10. No other changes were made. The operation of the injection devices and the use of the drug are unchanged.
Download DHPC / Information letter , Download_VeroeffentlichtAm_EN